Abvara Capital is a HealthTech MicroVC where we are focused on investing in pre-seed, seed and pre-Series A companies globally. We believe a new generation of healthtech companies are being built outside the US where they can innovate and iterate faster (lesser regulatory process delay) and bring innovative products to market faster. These companies can then expand globally in North America and Europe with well baked products and a deep competitive advantage. We are a team of entrepreneurs with tech and healthcare expertise and a strong network that we bring to each of our investments to connect the dots, get advice and a lot more. Abvara is a spin-off from Better Capital where we built a high quality portfolio in the last 5 quarter and are looking to apply the same formula with a deep focus on healthcare.
Abvara will syndicate all its deals and we are looking to build a global network for LPs who are big believes in Healthtech's future and may also come from this domain.